沙特阿拉伯儿童多发性硬化症患病率

IF 2.2 Q3 CLINICAL NEUROLOGY Multiple Sclerosis International Pub Date : 2021-11-09 eCollection Date: 2021-01-01 DOI:10.1155/2021/4226141
Reem Bunyan, Ghada Al Towaijri, Hessa Al Otaibi, Abid Kareem, Hussein Algahtani, Mousa Al Mejally, Ali Almubarak, Saad Alrajeh, Edward Cupler, Shireen Qureshi, Sadaga Alawi, Mamdouh Kalakatawi, Yaser Al Malik, Shahpar Nahrir, Adel Alhazzani, Ashraf El-Metwally, Sahar Shami, Samah Ishak, Hajer Almudaiheem, Ahmed Al-Jedai, Mohammed AlJumah
{"title":"沙特阿拉伯儿童多发性硬化症患病率","authors":"Reem Bunyan,&nbsp;Ghada Al Towaijri,&nbsp;Hessa Al Otaibi,&nbsp;Abid Kareem,&nbsp;Hussein Algahtani,&nbsp;Mousa Al Mejally,&nbsp;Ali Almubarak,&nbsp;Saad Alrajeh,&nbsp;Edward Cupler,&nbsp;Shireen Qureshi,&nbsp;Sadaga Alawi,&nbsp;Mamdouh Kalakatawi,&nbsp;Yaser Al Malik,&nbsp;Shahpar Nahrir,&nbsp;Adel Alhazzani,&nbsp;Ashraf El-Metwally,&nbsp;Sahar Shami,&nbsp;Samah Ishak,&nbsp;Hajer Almudaiheem,&nbsp;Ahmed Al-Jedai,&nbsp;Mohammed AlJumah","doi":"10.1155/2021/4226141","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, data on the pediatric onset of MS is lacking, particularly in developing countries.</p><p><strong>Objective: </strong>This study is aimed at reporting the current burden of the pediatric onset of MS in the five regions of Saudi Arabia.</p><p><strong>Methods: </strong>This study used relevant data from the National Saudi MS Registry that was operational between 2015 and 2018. The data on patients with pediatric onset MS from all the hospitals included in the registry was retrospectively analyzed using the age of diagnosis. Patients who were 1-18 years old when diagnosed were included in the analysis.</p><p><strong>Results: </strong>The registry included 287 patients with pediatric onset MS, with a mean age of diagnosis at 15.7 (SD: 2.06). 74.2% of the participants were females. For the included hospitals, the estimated prevalence of pediatric MS was at 2.73/100,000 pediatric Saudi population. The prevalence of pediatric MS in the remaining nonparticipant hospitals was then projected taking into account both the size of pediatric population in the Kingdom per region and the number of facilities treating and managing MS in each of the corresponding regions. The overall projected prevalence was found to be 14.33/100,000 Saudi pediatric population.</p><p><strong>Conclusion: </strong>To the best of our knowledge, this study reported the latest epidemiological data of pediatric onset of MS in Saudi Arabia. The current prevalence of MS among the pediatric Saudi population was found to be 2.73/100,000, and the overall projected prevalence was estimated at 14.33/100,000. Our findings were similar to those in other pediatric MS cohorts. Further studies are needed to understand the long-term prognosis, response to treatment, and disease course.</p>","PeriodicalId":46096,"journal":{"name":"Multiple Sclerosis International","volume":"2021 ","pages":"4226141"},"PeriodicalIF":2.2000,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595009/pdf/","citationCount":"3","resultStr":"{\"title\":\"Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia.\",\"authors\":\"Reem Bunyan,&nbsp;Ghada Al Towaijri,&nbsp;Hessa Al Otaibi,&nbsp;Abid Kareem,&nbsp;Hussein Algahtani,&nbsp;Mousa Al Mejally,&nbsp;Ali Almubarak,&nbsp;Saad Alrajeh,&nbsp;Edward Cupler,&nbsp;Shireen Qureshi,&nbsp;Sadaga Alawi,&nbsp;Mamdouh Kalakatawi,&nbsp;Yaser Al Malik,&nbsp;Shahpar Nahrir,&nbsp;Adel Alhazzani,&nbsp;Ashraf El-Metwally,&nbsp;Sahar Shami,&nbsp;Samah Ishak,&nbsp;Hajer Almudaiheem,&nbsp;Ahmed Al-Jedai,&nbsp;Mohammed AlJumah\",\"doi\":\"10.1155/2021/4226141\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, data on the pediatric onset of MS is lacking, particularly in developing countries.</p><p><strong>Objective: </strong>This study is aimed at reporting the current burden of the pediatric onset of MS in the five regions of Saudi Arabia.</p><p><strong>Methods: </strong>This study used relevant data from the National Saudi MS Registry that was operational between 2015 and 2018. The data on patients with pediatric onset MS from all the hospitals included in the registry was retrospectively analyzed using the age of diagnosis. Patients who were 1-18 years old when diagnosed were included in the analysis.</p><p><strong>Results: </strong>The registry included 287 patients with pediatric onset MS, with a mean age of diagnosis at 15.7 (SD: 2.06). 74.2% of the participants were females. For the included hospitals, the estimated prevalence of pediatric MS was at 2.73/100,000 pediatric Saudi population. The prevalence of pediatric MS in the remaining nonparticipant hospitals was then projected taking into account both the size of pediatric population in the Kingdom per region and the number of facilities treating and managing MS in each of the corresponding regions. The overall projected prevalence was found to be 14.33/100,000 Saudi pediatric population.</p><p><strong>Conclusion: </strong>To the best of our knowledge, this study reported the latest epidemiological data of pediatric onset of MS in Saudi Arabia. The current prevalence of MS among the pediatric Saudi population was found to be 2.73/100,000, and the overall projected prevalence was estimated at 14.33/100,000. Our findings were similar to those in other pediatric MS cohorts. Further studies are needed to understand the long-term prognosis, response to treatment, and disease course.</p>\",\"PeriodicalId\":46096,\"journal\":{\"name\":\"Multiple Sclerosis International\",\"volume\":\"2021 \",\"pages\":\"4226141\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2021-11-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595009/pdf/\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Multiple Sclerosis International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2021/4226141\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/4226141","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 3

摘要

背景:多发性硬化症(MS)的患病率似乎在全球范围内呈上升趋势。然而,关于小儿发病多发性硬化症的数据缺乏,特别是在发展中国家。目的:本研究旨在报告目前沙特阿拉伯五个地区儿童发病MS的负担。方法:本研究使用了2015年至2018年期间运行的沙特国家多发性硬化症登记处的相关数据。所有纳入登记的医院的儿童发病多发性硬化症患者的数据采用诊断年龄进行回顾性分析。诊断时年龄在1-18岁的患者被纳入分析。结果:登记包括287例儿科发病MS患者,平均诊断年龄为15.7岁(SD: 2.06)。74.2%的参与者为女性。在纳入的医院中,儿童多发性硬化的估计患病率为2.73/100,000沙特儿童人口。然后,考虑到王国每个地区的儿科人口规模和每个相应地区治疗和管理多发性硬化症的设施数量,对其余非参与医院的儿科多发性硬化症患病率进行了预测。总体预测患病率为14.33/10万沙特儿童人口。结论:据我们所知,本研究报告了沙特阿拉伯儿童发病MS的最新流行病学资料。目前沙特儿童人群中MS的患病率为2.73/10万,总体预计患病率估计为14.33/10万。我们的发现与其他儿童多发性硬化症队列相似。需要进一步的研究来了解长期预后、对治疗的反应和病程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Prevalence of Pediatric Onset Multiple Sclerosis in Saudi Arabia.

Background: The prevalence of multiple sclerosis (MS) appears to be increasing worldwide. However, data on the pediatric onset of MS is lacking, particularly in developing countries.

Objective: This study is aimed at reporting the current burden of the pediatric onset of MS in the five regions of Saudi Arabia.

Methods: This study used relevant data from the National Saudi MS Registry that was operational between 2015 and 2018. The data on patients with pediatric onset MS from all the hospitals included in the registry was retrospectively analyzed using the age of diagnosis. Patients who were 1-18 years old when diagnosed were included in the analysis.

Results: The registry included 287 patients with pediatric onset MS, with a mean age of diagnosis at 15.7 (SD: 2.06). 74.2% of the participants were females. For the included hospitals, the estimated prevalence of pediatric MS was at 2.73/100,000 pediatric Saudi population. The prevalence of pediatric MS in the remaining nonparticipant hospitals was then projected taking into account both the size of pediatric population in the Kingdom per region and the number of facilities treating and managing MS in each of the corresponding regions. The overall projected prevalence was found to be 14.33/100,000 Saudi pediatric population.

Conclusion: To the best of our knowledge, this study reported the latest epidemiological data of pediatric onset of MS in Saudi Arabia. The current prevalence of MS among the pediatric Saudi population was found to be 2.73/100,000, and the overall projected prevalence was estimated at 14.33/100,000. Our findings were similar to those in other pediatric MS cohorts. Further studies are needed to understand the long-term prognosis, response to treatment, and disease course.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Multiple Sclerosis International
Multiple Sclerosis International CLINICAL NEUROLOGY-
自引率
0.00%
发文量
6
审稿时长
15 weeks
期刊介绍: Multiple Sclerosis International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to all aspects of multiple sclerosis, including clinical neurology, neuroimaging, neuropathology, therapeutics, genetics, neuroimmunology, biomarkers, psychology and neurorehabilitation.
期刊最新文献
White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years. Pulp Sensitivity Testing in Multiple Sclerosis: Disease Duration and Sensory/Motor Associations-A Cross-Sectional Study. Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis. Cognitive Contributors of Backward Walking in Persons with Multiple Sclerosis. Patient and Clinician Perspectives of Physical Therapy for Walking Difficulties in Multiple Sclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1